必博(中国)Bibo·官方网站

Investor

Stock Information

A share
H share
Stock Code

600276.SH

+1.08

+1.48%

  • Today's Open

    72.96RMB

  • Day High

    74.15RMB

  • Day Low

    71.55RMB

  • Previous Close

    72.96RMB

  • Turnover Rate

    0.69%

  • Range%

    3.56%

  • Volume

    43.84万手

  • Market Capitalization

    4598.51亿

Stock Code

1276.HK

+1.08

+1.48%

  • Today's Open

    72.96RMB

  • Day High

    74.15RMB

  • Day Low

    71.55RMB

  • Previous Close

    72.96RMB

  • Turnover Rate

    0.69%

  • Range%

    3.56%

  • Volume

    43.84万手

  • Market Capitalization

    4598.51亿

Announcements

  • 2025-06-05

    Announcements and Notices - [Overseas Regulatory Announcement - Other] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

  • 2025-06-05

    Announcements and Notices - [Overseas Regulatory Announcement - Other] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

  • 2025-06-05

    Monthly Returns Monthly Return of Equity Issuer on Movements in Securities for the month ended May 31, 2025

  • 2025-05-30

    Announcements and Notices - [Overseas Regulatory Announcement - Other] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

  • 2025-05-29

    Announcements and Notices - [Overseas Regulatory Announcement - Other] Overseas Regulatory Announcement - Announcement in Relation to the Approval for Drug Registration

  • 2025-05-29

    Announcements and Notices - [Overseas Regulatory Announcement - Other] Overseas Regulatory Announcement - Announcement in Relation to the Approval for Drug Registration

  • 2025-05-29

    Announcements and Notices - [Overseas Regulatory Announcement - Other] Overseas Regulatory Announcement - Announcement in Relation to the Approval for Drug Registration

  • 2025-05-26

    Announcements and Notices - [Overseas Regulatory Announcement - Other] An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

  • 2025-05-23

    Announcements and Notices - [Allotment Results] (Revised) Announcement of Final Offer Price and Allotment Results

  • 2025-05-22

    Announcements and Notices - [Allotment Results] Announcement of Final Offer Price and Allotment Results

  • 2025-05-22

    Announcements and Notices - [List of Directors and their Role and Function] List of Directors and Their Roles and Functions

  • 2025-05-22

    Announcements and Notices - [Terms of Reference of Other Board Committees] Terms of Reference of the Strategy Committee of the Board of Directors

  • 2025-05-22

    Announcements and Notices - [Terms of Reference of the Nomination Committee] Terms of Reference of the Nomination Committee of the Board of Directors

  • 2025-05-22

    Announcements and Notices - [Terms of Reference of the Remuneration Committee] Terms of Reference of the Remuneration and Evaluation Committee of the Board of Directors

  • 2025-05-22

    Announcements and Notices - [Terms of Reference of the Audit Committee] Terms of Reference of the Audit Committee of the Board of Directors

  • 2025-05-22

    Constitutional Documents Articles of Association

  • 2025-05-21

    Announcements and Notices - [Other - Miscellaneous] ANNOUNCEMENT OF OFFER PRICE

  • 2025-05-15

    Documents on Display Documents on Display

  • 2025-05-15

    Announcements and Notices - [Formal Notice] GLOBAL OFFERING

Governance Documents

2025.05.22

Terms of Reference of the Audit Committee of the Board of Directors

view source

2025.05.22

Terms of Reference of the Remuneration and Evaluation Committee of the Board of Directors

view source

2025.05.22

Terms of Reference of the Nomination Committee of the Board of Directors

view source

2025.05.22

Terms of Reference of the Strategy Committee of the Board of Directors

view source

2025.05.22

Procedures for Shareholders to Propose a Person for Election as a Director of the Company

view source

2025.05.22

Shareholders Communication Policy

view source

ESG report

ESG policy

MORE

Divident Information

No. Financial Year Entitlement Date(yy-mm-dd) Dividend per 10 Share(pre-tax.RMB Yuan) Scrip Issue Per 10 Shares(Share) Number of bonus Shares for every 10 shares(share) Total cash bonus(pre-tax.RMB Ten Thousand Yuan)
1 2024 2025.05.23 2.0 0 0 127,413.02
2 2023 2024.07.12 2.0 0 0 127,376.83
3 2022 2023.06.08 1.6 0 0 101,987.33
4 2021 2022.07.05 1.6 0 0 102,046.65
5 2020 2021.06.10 2.0 2 0 106,624.63
6 2019 2020.05.25 2.3 2 0 101,712.71
7 2018 2019.03.28 2.2 2 0 81,088.97
8 2017 2018.05.30 1.3 2 1 36,824.42
9 2016 2017.05.31 1.35 2 0 31,690.71
10 2015 2016.06.16 1.0 2 0 19,564.69
11 2014 2015.06.15 1.0 2 1 15050.16
12 2013 2014.05.15 0.9 1 0 12,241.99
13 2012 2013.06.07 0.8 1 0 9,892.52
14 2011 2012.05.29 0.9 1 0 10,117.35
15 2010 2011.04.26 1.0 3 2 7494.33
16 2009 2010.03.17 1.0 2 0 6,207.43
17 2008 2009.04.30 1.0 2 0 5,172.86
18 2007 2008.04.11 1.0 2 0 4,310.72
19 2006 2007.04.02 1.6 3 0 5,305.50
20 2006 2006.08.29 0.0 3 0 0
21 2005 2006.07.18 2.2 0 0 5,611.58
22 2004 2005.06.16 2.0 0 0 5,101.44
23 2003 2004.05.28 1.0 0 0 2,550.72
24 2002 2003.08.07 1.0 0 0 2,550.72
25 2001 2002.05.21 0.5 2 0 1,062.80
26 2000 2001.05.11 1.0 3 3 1,328.50

Investor Contact

Telephone:

Email:

Fax:

+86-21-61063801

Address:

1288 Haike Road, Pudong New Area, Shanghai, China